Poly(I:C)-Mediated Tumor Growth Suppression in EGF-Receptor Overexpressing Tumors Using EGF-Polyethylene Glycol-Linear Polyethylenimine as Carrier

Author： Schaffert David   Kiss Melinda   Rödl Wolfgang   Shir Alexei   Levitzki Alexander   Ogris Manfred   Wagner Ernst  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.28, Iss.4, 2011-04, pp. : 731-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach

By Loupakis Fotios   Vasile Enrico   Santini Daniele   Masi Gianluca   Falcone Alfredo   Graziano Francesco  

Pharmacogenomics, Vol. 9, Iss. 1, 2008-01 ,pp. : 55-69

Future Medicine

Access to resources Recommend Favorite

Compounds and methods for the treatment of EGF receptor associated cancers and purification of the EGF receptor

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 8, 1997-08 ,pp. : 895-897

Informa Healthcare

Access to resources Recommend Favorite

Targeting the EGF receptor ectodomain in the context of cancer

By Huang Lieven   De Baetselier Patrick   Beyaert Rudi  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1347-1361

Informa Healthcare

Access to resources Recommend Favorite

The EGF receptor as central transducer of heterologous signalling systems

By Zwick E.   Hackel P.O.   Prenzel N.   Ullrich A.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 10, 1999-10 ,pp. : 408-412

Elsevier

Access to resources Recommend Favorite

EGF Receptor as a Drug Target in Arterial Hypertension

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-05 ,pp. : 526-538

Bentham Science Publishers

Access to resources Recommend Favorite